美国国立卫生研究院的研究发现，与低热量饮食相比，胃绕道手术和新型减肥药可使减肥平台期延长一倍。 NIH study finds gastric bypass surgery and new weight loss drugs double weight loss plateau time compared to calorie deficit diets.
美国国立卫生研究院最近的一项研究发现，与低热量饮食相比，胃绕道手术和 Wegovy 和 Zepbound 等新型减肥药可以使达到减肥平台期所需的时间延长一倍。 A recent study from the National Institutes of Health found that gastric bypass surgery and new weight loss drugs like Wegovy and Zepbound can double the time it takes to hit a weight loss plateau compared to calorie deficit diets. 这是因为，随着人们体重减轻，食欲也会增强，从而抵消他们的努力。 This is due to stronger appetite growth as people lose more weight, which can counteract their efforts. 该研究由研究员凯文·霍尔 (Kevin Hall) 领导，利用高质量临床试验的数据来了解和模拟减肥平台期。 The study, led by researcher Kevin Hall, used data from high-quality clinical trials to understand and model weight loss plateaus.